Table 2.
Univariate analysis of survival outcomes.
| Parameters | Overall survival | Disease-free survival | Breast cancer specific survival | |||
|---|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% C) | P | HR (95% CI) | P | |
| AR expression | ||||||
| Negative | 1 | 1 | 1 | |||
| Positive | 0.71 (0.38-1.33) | 0.3 | 1.07 (0.62-1.86) | 0.8 | 0.93 (0.44-1.95) | 0.839 |
| Tumor Size | ||||||
| T1 | 1 | 1 | 1 | |||
| T2 | 2.92 (0.68, 12.5) | 0.15 | 3.9 (0.92, 16.5) | 0.065 | 3.67 (0.48-28.22) | 0.212 |
| T3&T4 | 8.79 (2.08-37.2) | 0.003 | 9.21 (2.17-39) | 0.003 | 11.75 (1.56-88.54) | 0.017 |
| Lymph node status | ||||||
| N0 | 1 | 1 | 1 | |||
| N1 | 3.39 (1.67, 6.87) | < 0.001 | 2.46 (1.33, 4.54) | 0.004 | 4.56 (1.82-11.43) | 0.001 |
| N2&N3 | 5.07 (2.09-12.3) | < 0.001 | 3.91 (1.72, 8.92) | 0.001 | 5.12 (1.56-16.84) | 0.007 |
| Neoadjuvant CTx | ||||||
| No | 1 | 1 | 1 | |||
| Yes | 2.52 (1.3, 4.89) | 0.006 | 1.58 (0.9, 2.79) | 0.11 | 3.49 (1.42-8.57) | 0.006 |
| Adjuvant CTx | ||||||
| No | 1 | 1 | 1 | |||
| Yes | 0.74 (0.42, 1.33) | 0.3 | 0.9 (0.52, 1.53) | 0.7 | 0.82 (0.40-1.68) | 0.588 |
| Radiotherapy treatment | ||||||
| No | 1 | 1 | 1 | |||
| Yes | 1.04 (0.54, 1.97) | 0.9 | 0.87 (0.49, 1.55) | 0.6 | 0.93 (0.43-2.04) | 0.864 |
| Surgery type | ||||||
| BCS | 1 | 1 | 1 | |||
| Mastectomy ± Reconstruction | 3.99 (1.98, 8.07) | < 0.001 | 2.61 (1.43-4.74) | 0.002 | 5.48 (2.09-14.34) | 0.001 |
HR, Hazard ratio; CI, Confidence interval.